β Receptors: role in cardiometabolic disorders
Pharmacological and molecular approaches have shown that an atypical β-adrenoceptor (AR), called β 3 -AR, that is distinct from β 1 -ARs and β 2 -ARs, exists in some tissues in heterogeneous populations such as β 3a -ARs and β 3b -ARs. β 3 -ARs belong to a superfamily of receptors linked to guanine...
Main Authors: | Shraddha V. Bhadada, Bhoomika M. Patel, Anita A. Mehta, Ramesh K. Goyal |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-04-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/2042018810390259 |
Similar Items
-
Evaluation of Buspirone on Streptozotocin Induced Type 1 Diabetes and Its Associated Complications
by: Suchi Raghunathan, et al.
Published: (2014-01-01) -
Emerging roles of Toll-like receptor 9 in cardiometabolic disorders
by: Sachiko Nishimoto, et al.
Published: (2020-07-01) -
Osteoprotegerin in Cardiometabolic Disorders
by: C. Pérez de Ciriza, et al.
Published: (2015-01-01) -
Cardiometabolic disorders and menopausal hormone therapy
by: V Ye Balan, et al.
Published: (2017-10-01) -
Adiponectin beyond cardiometabolic disorders
by: Juen-Haur Hwang
Published: (2011-12-01)